Company: SHPH
Filing Date: 2025-03-05
Form Type: S-1/A
Source: 0001493152-25-009106
Chunk: 61

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-05
Form: S-1/A
Chunk 61
---
piggyback” registration rights.

| 38 |

Additional Information

The foregoing is only a summary of the material terms of the January 2023 SPA, the January 2023 Convertible Note, the January 2023 Warrant, the Registration Rights Agreement, and the other ancillary transaction documents, and does not purport to be a complete description of the rights and obligations of the parties thereunder.

October 2024 Convertible Notes and Warrants Offering

In October 2024, we sold a total of $831,579 of 5%
original issue discount senior secured convertible notes, which notes convert into 732,134 shares of common stock, subject to adjustment,
and warrants to purchase 329,469 shares of common stock exercisable at a variable-weighted average of $1.42 per share. The convertible
notes have a term of one year, are may be converted at any time by the holder and are subject to mandatory conversion at the end of the
one-year holding period in the event the convertible notes are registered. The warrants have a term of five years and contain standard
anti-dilution protections.

October 2024 Public Offering Warrants

In conjunction with our October 2024
public offering, we issued pre-funded warrants to purchase 2,555,246 shares of common stock exercisable at $0.001 per share, and
warrants to purchase a total of 2,950,820 shares of common stock exercisable at $1.40 per share. The warrants are exercisable, at the
option of the holder, for a period of five years and are subject to either a 4.99% or 9.99% ownership limitation.
However, any holder may increase or decrease such percentage so long as it does not exceed 9.99%. The pre-funded warrants and
warrants are not transferrable without the consent of the Company and the holders have no voting rights until the warrants are exercised.

Anti-Takeover Effects of Provisions of our Certificate of Incorporation, our By-laws and Delaware Law

Some provisions of Delaware law, our certificate of incorporation and our by-laws contain provisions that could make the following transactions more difficult: acquisition of us by means of a tender offer; acquisition of us by means of a proxy contest or otherwise; or removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or